This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Assessing and Measuring Nonresponse in Schizophrenia

John M. Kane, MD

Published: January 15, 2012

Article Abstract

Symptom resolution, relapse prevention, and recovery of function are the goals of schizophrenia treatment. Often, clinicians rely on clinical impressions and informal interviews to judge whether treatment strategies are achieving these goals. However, measurement-based rating scales can assist clinicians in diagnosing patients, as well as in assessing their treatment response, evaluating the tolerability of adverse effects, and documenting the efficacy of treatment trials. Evaluating early treatment response or nonresponse can help clinicians in formulating long-term strategies to help patients achieve optimal outcomes.


This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Related Articles

Volume: 73

Quick Links: